Search for: "Warner-Lambert Company, LLC."
Results 21 - 40
of 97
Sorted by Relevance
|
Sort by Date
18 Dec 2009, 9:59 am
(patent infringement) 12/3: Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company and Warner-Lambert Company LLC v. [read post]
7 Dec 2016, 11:58 pm
In addition, last month, the Court of Appeal upheld Arnold J’s findings on the validity of the Patent and the amendment/abuse of process issues but disagreed with him, obiter, on issues concerning the construction and infringement of Swiss Type Claims (Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006). [read post]
25 Mar 2008, 9:57 am
., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC and Warner-Lambert Export [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/23: Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company and Warner-Lambert Company, LLC v. [read post]
1 Feb 2011, 4:01 am
When the direct purchasers, who are really wholesale dealers several steps removed from patients, come in, though, it's a different story entirely, like in the Neurotin decision last week from the District Court for New Jersey: Plaintiffs in the instant action each directly purchased Neurontin, a brand-name version of the drug compound gabapentin anhydrous ('gabapentin'), from Defendants Pfizer, Inc. and Warner-Lambert Company, LLC… [read post]
9 Mar 2015, 12:23 pm
.* Warner-Lambert v Actavis Mark 4: harmony between parties in ‘lyrical’ patent disputeLast Thursday, Jeremy reported a High Court Order obtained by Warner-Lambert (part of the Pfizer group) mandating the NHS to release guidance about the prescribing of pregabalin (Warner-Lambert Company, LLC v Actavis Group PTC EHF & Others[2015] EWHC 485 (Pat) (02 March 2015)) [on which see the IPKat earlier posts, here and… [read post]
17 Feb 2010, 8:00 am
Pfizer Inc., Pfizer Pharmaceuticals LLC, Pfizer Ireland Pharmaceuticals, Pfizer Limited and CP Pharmaceuticals International CV, Warner-Lambert Company and Warner-Lambert Company LLC (patent infringement) [read post]
24 Oct 2016, 2:35 am
While this moggy was struggling to get back from Indonesia, the Court of Appeal handed down its decision in the pregabalin appeal Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (13 October 2016), and finally the IPKat has managed to blog about it (the lateness by no means reflecting on the importance of the judgment).It is very much a judgment of three halves.In the first part of the judgment (up to [135]), which… [read post]
28 Feb 2015, 4:26 am
Australia’s competition watchdog has failed to convince a Federal Court judge that a strategy employed by pharmaceutical company Pfizer, to enter the market for generic products upon expiry of its patent covering blockbuster cholesterol-lowering drug LIPITOR, constituted an illegal misuse of market power, or ‘exclusive dealing’: Australian Competition and Consumer Commission v Pfizer Australia Pty Ltd [2015] FCA 113.From the year 2000, when it acquired Warner… [read post]
15 Jun 2015, 7:13 am
Almost all of these updates have been compiled and crafted by our good friend and dedicated colleague Alberto Bellan, to whom the IPKat and Merpel raise their paws in a respectful and grateful salute.Don't forget: there's also a mini-summary at the bottom of the post that lists the features carried by this weblog over the previous month.Last week's substantive Katposts look like this:* Swiss claims: a Kat reflects on the Warner-Lambert v Actavis appealAfter… [read post]
16 May 2011, 4:30 am
Warner-Lambert, Co., 265 F.3d 853 (9th Cir. 2001), noted that in diversity cases, the complaint must affirmatively allege the state of citizenship of each party. [read post]
31 May 2015, 3:47 am
Last week the Court of Appeal said that was incorrect in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWCA Civ 556, and that actually all that is required is for the infringer to know, or be able to reasonably foresee, that the medicament would be used to treat the condition (Katpost here). [read post]
29 Nov 2007, 7:45 am
Medtronic and Warner-Lambert v. [read post]
2 Mar 2015, 2:43 pm
. * Warner-Lambert v Actavis Mark 3: a "lyrical" solution to a painful patent disputeAfter the Patents Court ruling of Mr Justice Arnold in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others, which Darren reported here, Jeremy has got some news to break on that painful patent war.* Blind faith not enough when proving bad faith: a case of ColourblindnessValentina reports on a fresh trade mark dispute that the General Court… [read post]
9 Feb 2015, 1:15 am
* Warner-Lambert v Actavis Mark 2, still at first instance: more on Swiss claims, Skinny Labels, and no StrikeoutDarren covers another Arnoldian decision in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 223 (Pat). [read post]
19 Nov 2008, 9:04 am
Warner-Lambert & Co., 467 F.3d 85, 97 (2d Cir.2006)(same Michigan statute was not preempted by Buckman), affirmed sub nom, Warner-Lambert Co., LLC v. [read post]
9 Nov 2009, 6:01 am
In the agreement the lawyers eventually hammered out, the Pfizer unit, Warner-Lambert, pleaded guilty to two felony counts of marketing a drug for unapproved uses. [read post]
29 Jun 2015, 9:36 am
A futuristic Neil imagines a time when consumers’ psychological/neurological associations could be measured (also) for the sake of assess a trade marks’ reputation* Case management decisions in the Lyrica caseThe ongoing case between Warner-Lambert (a subsidiary of Pfizer) and Actavis concerning pregabalin (sold by Pfizer under the trade mark Lyrica, and by Actavis under the trade mark Lecaent) seems set to be the case of the year, Darren says. [read post]
4 Mar 2018, 4:02 am
However, a patent application must be filed as early as possible to ensure that any available protection is secured in the event that the trials are successful.A recent appeal decision of a Full Bench of the Federal Court of Australia sheds light on how the balance between an innovator’s need to file early, and the community’s right to receive a full disclosure of the invention, is struck in the case of a patent for a new therapeutic use of a known compound:… [read post]
26 Jan 2015, 4:03 am
.* No pain for Actavis: Warner-Lambert fail to stop launch of generic pregabalinSecond medical use claims, skinny labels, and public policy issues around healthcare are the topics addressed in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 72 (Pat) (21 January 2015), a decision that Mr Justice Arnold has just delivered and on which Darren timely comments in this post.* BREAKING NEWS: CJEU says exhaustion… [read post]
